Lung ultrasound for early diagnosis and severity assessment of pneumonia in patients with coronavirus disease 2019
- Author:
Young-Jae CHO
1
;
Kyoung-Ho SONG
;
Yunghee LEE
;
Joo Heung YOON
;
Ji Young PARK
;
Jongtak JUNG
;
Sung Yoon LIM
;
Hyunju LEE
;
Ho Il YOON
;
Kyoung Un PARK
;
Hong Bin KIM
;
Eu Suk KIM
Author Information
- Publication Type:102
- From:The Korean Journal of Internal Medicine 2020;35(4):771-781
- CountryRepublic of Korea
-
Abstract:
Background/Aims:Current evidence supports lung ultrasound as a point-ofcare alternative diagnostic tool for various respiratory diseases. We sought to determine the utility of lung ultrasound for early detection of pneumonia and for assessment of respiratory failure among patients with coronavirus disease 2019 (COVID-19).
Methods:Six patients with confirmed COVID-19 by reverse transcription-polymerase chain reaction were enrolled. All had undergone chest X-ray and chest computed tomography (CT) on the day of admission and underwent multiple point-of-care lung ultrasound scans over the course of their hospitalization.
Results:Lung ultrasound detected early abnormal findings of representative B-lines in a patient with a normal chest X-ray, corresponding to ground-glass opacities on the chest CT scan. The ultrasound findings improved as her clinical condition improved and her viral load decreased. In another minimally symptomatic patient without significant chest X-ray findings, the ultrasound showed B-lines, an early sign of pneumonia before abnormalities were detected on the chest CT scan. In two critically ill patients, ultrasound was performed to assess for evaluation of disease severity. In both patients, the clinicians conducted emergency rapid sequence intubation based on the ultrasound findings without awaiting the laboratory results and radiological reports. In two children, ultrasound was used to assess the improvement in their pneumonia, thus avoiding further imaging tests such as chest CT.
Conclusions:Lung ultrasound is feasible and useful as a rapid, sensitive, and affordable point-of-care screening tool to detect pneumonia and assess the severity of respiratory failure in patients hospitalized with COVID-19.
